Shingles & Chickenpox: Why the Virus Returns – Expert Explains

Most of us remember the itchy discomfort of chickenpox as a childhood rite of passage. But the virus that causes it, varicella-zoster virus (VZV), doesn’t simply disappear after the spots fade. It can lie dormant within our nervous system for decades, potentially re-emerging later in life as shingles – a condition that can cause significant pain and complications. Recent discussions, including a conversation with Associate Professor Theresa Larkin, are shedding light on why this happens, how to recognize the signs, and what treatment options are available.

Understanding Viral Dormancy

The journey from chickenpox to shingles begins with the initial VZV infection. Once someone recovers from chickenpox, the virus doesn’t leave the body entirely. Instead, it travels along nerve pathways and settles into nerve ganglia – clusters of nerve cells – near the spinal cord and brain. Here, it can remain inactive, or dormant, for years, even a lifetime. Associate Professor Larkin’s work focuses on understanding the mechanisms that keep the virus in this latent state, and what triggers its reactivation.

Why does the virus reactivate? Although the exact reasons aren’t fully understood, a weakening of the immune system is a key factor. This weakening can be due to age, illness, stress, or certain medications that suppress the immune response. As we get older, our immune system naturally becomes less efficient at keeping VZV in check, increasing the risk of shingles.

The Pain of Shingles: More Than Just a Rash

Shingles isn’t simply a more adult version of chickenpox. While it also presents as a rash, the pain associated with shingles is often far more intense and debilitating. The rash typically appears as a band of blisters on one side of the body, often on the torso, but it can occur anywhere. This distribution follows the path of the affected nerve.

The pain can commence days before the rash appears, described as burning, shooting, or stabbing. Even after the rash clears, a significant number of people experience postherpetic neuralgia (PHN), a chronic nerve pain that can last for months or even years. The severity of pain and the risk of PHN increase with age.

Recognizing Symptoms and Seeking Timely Treatment

Early recognition of shingles symptoms is crucial for effective management. Besides the characteristic painful rash, other symptoms can include fever, headache, fatigue, and sensitivity to touch. It’s important to note that shingles is not contagious in the same way as chickenpox. However, someone with an active shingles rash can spread VZV to people who have never had chickenpox, potentially causing them to develop the childhood illness. The Centers for Disease Control and Prevention (CDC) provides detailed information on transmission and prevention.

Antiviral medications are the primary treatment for shingles. These medications, such as acyclovir, valacyclovir, and famciclovir, can help reduce the severity and duration of the illness, and lower the risk of PHN. They are most effective when started within 72 hours of the rash appearing. Pain management is also an important part of treatment, and may involve over-the-counter pain relievers, prescription medications, or other therapies.

Vaccination: A Powerful Preventative Measure

The most effective way to protect against shingles is vaccination. Two shingles vaccines are currently available: Shingrix and Zostavax. The National Health Service (NHS) offers guidance on shingles vaccination in the UK. Shingrix is now the preferred vaccine, as it provides greater and longer-lasting protection than Zostavax. It’s recommended for adults aged 50 years and older, even if they’ve had shingles before or received the older Zostavax vaccine.

Shingrix is a non-live vaccine, meaning it doesn’t contain the live virus and cannot cause shingles. It works by boosting the immune system’s ability to fight off VZV. Studies have shown that Shingrix is highly effective in preventing shingles and PHN.

Understanding Vaccine Effectiveness

It’s important to understand that vaccines aren’t 100% effective, but they significantly reduce the risk of infection. While Shingrix is over 90% effective in preventing shingles, some vaccinated individuals may still develop the condition. However, even in these cases, the illness is typically milder and less likely to lead to complications.

The Ongoing Research Landscape

Research into VZV and shingles continues to evolve. Scientists are working to better understand the factors that influence viral reactivation, develop more effective treatments, and improve vaccine strategies. Associate Professor Larkin’s research contributes to this broader understanding of the virus and its long-term effects. Further investigation is needed to explore the potential role of the immune system and genetic factors in shingles development.

Public health surveillance plays a vital role in monitoring shingles incidence and identifying trends. This information helps inform vaccination recommendations and public health interventions. Ongoing monitoring of vaccine effectiveness is also crucial to ensure that vaccination programs remain effective over time.

What to do if you suspect shingles: If you experience a painful rash, especially if it’s on one side of your body and accompanied by other symptoms like fever or headache, it’s important to consult a healthcare professional promptly. Early diagnosis and treatment can significantly improve outcomes and reduce the risk of complications.